Artwork

Sisällön tarjoaa Cover2 Resources and Cover 2 Resources. Cover2 Resources and Cover 2 Resources tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Ep. 261 - The True Cost of the Opioid Crisis

26:44
 
Jaa
 

Manage episode 247961579 series 1052357
Sisällön tarjoaa Cover2 Resources and Cover 2 Resources. Cover2 Resources and Cover 2 Resources tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In August, a closely watched Oklahoma opioid trial concluded. Johnson & Johnson was found guilty of deceptive marketing practices and public nuisance, the judge awarded the state $572 Million to cover the first year of abatement. However, the judge later announced he had made a $107 million miscalculation. Instead of $572 million, the amount awarded to Oklahoma was actually $465 Million. The miscalculation brought an outcry among Oklahoma state attorneys, mental health specialists, and addiction experts. All claim that the true cost of the opioid crisis is much higher than $572 million, and will take at least 20 years to resolve. After this surprising announcement, we decided to try to answer the question: What are the latest cost estimates of the opioid crisis, and how do they correlate to the judgment awarded in Oklahoma? Our guests on today’s episode, Dale Hall and Dr. Christopher Ruhm, share the results of their research. Together, they detail the massive financial burden Big Pharma has placed on our country and break down the Judge’s award against Johnson & Johnson. Join us for today’s podcast with Dale Hall and Dr. Christopher Ruhm, to hear the true cost of the opioid crisis.
  continue reading

284 jaksoa

Artwork
iconJaa
 
Manage episode 247961579 series 1052357
Sisällön tarjoaa Cover2 Resources and Cover 2 Resources. Cover2 Resources and Cover 2 Resources tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In August, a closely watched Oklahoma opioid trial concluded. Johnson & Johnson was found guilty of deceptive marketing practices and public nuisance, the judge awarded the state $572 Million to cover the first year of abatement. However, the judge later announced he had made a $107 million miscalculation. Instead of $572 million, the amount awarded to Oklahoma was actually $465 Million. The miscalculation brought an outcry among Oklahoma state attorneys, mental health specialists, and addiction experts. All claim that the true cost of the opioid crisis is much higher than $572 million, and will take at least 20 years to resolve. After this surprising announcement, we decided to try to answer the question: What are the latest cost estimates of the opioid crisis, and how do they correlate to the judgment awarded in Oklahoma? Our guests on today’s episode, Dale Hall and Dr. Christopher Ruhm, share the results of their research. Together, they detail the massive financial burden Big Pharma has placed on our country and break down the Judge’s award against Johnson & Johnson. Join us for today’s podcast with Dale Hall and Dr. Christopher Ruhm, to hear the true cost of the opioid crisis.
  continue reading

284 jaksoa

Όλα τα επεισόδια

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas